NCT03935841View on ClinicalTrials.gov

Metabolic Differences of an Oral and Intravenous Dose of 3-hydroxybutyrate (3-OHB).

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 7, 2019

Primary Completion Date

November 1, 2019

Study Completion Date

March 1, 2020

Conditions
HealthyIncretin EffectKetosis
Interventions
DIETARY_SUPPLEMENT

3-OHB salt (NaCl)

36 gram 3-OHB salt diluted in 500 ml sterile water

Trial Locations (1)

8200

Department of Diabetes and Hormone Diseases (DoH), Aarhus N

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT03935841 - Metabolic Differences of an Oral and Intravenous Dose of 3-hydroxybutyrate (3-OHB). | Biotech Hunter | Biotech Hunter